Table of Content


Introduction
B-Cell Chronic Lymphocytic Leukemia - Overview
B-Cell Chronic Lymphocytic Leukemia - Therapeutics Development
B-Cell Chronic Lymphocytic Leukemia - Therapeutics Assessment
B-Cell Chronic Lymphocytic Leukemia - Companies Involved in Therapeutics Development
B-Cell Chronic Lymphocytic Leukemia - Drug Profiles
B-Cell Chronic Lymphocytic Leukemia - Dormant Projects
B-Cell Chronic Lymphocytic Leukemia - Discontinued Products
B-Cell Chronic Lymphocytic Leukemia - Product Development Milestones
Appendix



List of Figures

List of Figures
Number of Products under Development for B-Cell Chronic Lymphocytic Leukemia, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for B-Cell Chronic Lymphocytic Leukemia, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Target, 2021 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Mechanism of Action, 2021 (Contd..1)
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by AB Science SA, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Alexion Pharmaceuticals Inc, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by AstraZeneca Plc, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by BeiGene Ltd, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Beijing Immunochina Pharmaceuticals Co Ltd, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by BioIntegrator Ltd, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by BioInvent International AB, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by BioSplice Therapeutics Inc, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by BioXpress Therapeutics SA, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Bristol-Myers Squibb Co, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Chengdu USino Technology Biology Co Ltd, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by CRISPR Therapeutics AG, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Eisai Co Ltd, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Evive Biotech, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by iDD biotech SAS, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Kuur Therapeutics Ltd, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Loxo Oncology Inc, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Mediolanum farmaceutici SpA, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Merck & Co Inc, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Nordic Nanovector ASA, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Novartis AG, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Noxxon Pharma AG, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Regeneron Pharmaceuticals Inc, 2021
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Shanghai Pharmaceutical Group Co Ltd, 2021
B-Cell Chronic Lymphocytic Leukemia - Dormant Projects, 2021
B-Cell Chronic Lymphocytic Leukemia - Dormant Projects, 2021 (Contd..1)
B-Cell Chronic Lymphocytic Leukemia - Dormant Projects, 2021 (Contd..2)
B-Cell Chronic Lymphocytic Leukemia - Discontinued Products, 2021